ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,049.88
0.05%
US Tech 100
20,674.80
0.00%
Dow Jones
44,705.53
-0.17%
Brent Oil
73.665
0.08%
Bitcoin
96,674.32
0.73%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zymergen Inc (ZY) Quote

Zymergen Inc

Zymergen Inc (ZY)

NASDAQ
2.43
0.00
(0.00%)
Closed December 04 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.43
Bid
2.30
Ask
2.31
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
2.43
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

ZY Latest News

More News

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks...

October 19 2022
PR Newswire (US)

Ginkgo to Acquire Zymergen

Ginkgo to Acquire Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., July 25, 2022 Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology...

July 25 2022
PR Newswire (US)

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...

July 14 2022
GlobeNewswire Inc.

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to...

June 28 2022
GlobeNewswire Inc.

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular...

May 26 2022
GlobeNewswire Inc.

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...

May 24 2022
GlobeNewswire Inc.

Zymergen Reports Preliminary First Quarter 2022 Financial Results

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended...

May 12 2022
GlobeNewswire Inc.

Zymergen to Participate in the BofA Securities 2022 Healthcare Conference

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022...

April 29 2022
GlobeNewswire Inc.

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after...

April 13 2022
GlobeNewswire Inc.

Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and...

March 22 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.48
(0.00%)
0
AACGATA Creativity Global
$ 0.9752
(0.00%)
0
AALAmerican Airlines Group Inc
$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.48
(0.00%)
0
AACGATA Creativity Global
$ 0.9752
(0.00%)
0
AALAmerican Airlines Group Inc
$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.48
(0.00%)
0
AACGATA Creativity Global
$ 0.9752
(0.00%)
0

ZY Discussion

View Posts
janice shell janice shell 3 months ago
I know. I just posted to the last person who'd had something to say about this company.
👍️0
Triple nickle Triple nickle 3 months ago
My post date was 2022
👍️0
janice shell janice shell 3 months ago
What date? The complaint was filed in federal court today.
👍️0
Triple nickle Triple nickle 3 months ago
Check that date
👍️0
janice shell janice shell 3 months ago
fwiw:

SEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales Prospects

https://www.sec.gov/newsroom/press-releases/2024-129

The Complaint:

https://www.sec.gov/files/litigation/admin/2024/33-11303.pdf
👍️0
Triple nickle Triple nickle 3 years ago
About time here
👍️0
Wake Setter Wake Setter 3 years ago
Still a great opportunity here. Once all the law firms quit spamming the news wires for ZY and the company gives new guidance we could see some steps up.

$8.40 was a gift from God
👍️0
$treet $inatra $treet $inatra 3 years ago
great pop and even greater upside for the longer term holders, congrats!
👍️0
JstnDFW JstnDFW 3 years ago
Such a good buy this morning! Congrats to those that got in on early trading today.
👍️0
$treet $inatra $treet $inatra 3 years ago
yep, looking great!! back to $35+
👍️0
Roadtojourney Roadtojourney 3 years ago
Kathy wood bought 2.5 milly as well??
👍️0
JstnDFW JstnDFW 3 years ago
Back to 20-30 dollar range here!
👍️0
Wake Setter Wake Setter 3 years ago
ZY good chance for recovery here, great entry for synthetic bio industry. Dramatically oversold - over reaction.
👍️0
ciciagt ciciagt 3 years ago
Yes, news is bad. Softbank and others can’t be pleased. Issues with Hyaline, management shake up, and maybe ‘meager’ revenues in 2022. Pitiful.
👍️0
conix conix 3 years ago
No revenues and no CEO.
👍️0
ciciagt ciciagt 3 years ago
Yikes….
👍️0
Lowjack Lowjack 3 years ago
Did you at least get a chance to bend over first?

Holy CF!
👍️0
ciciagt ciciagt 3 years ago
I own Zymergen and watching a SPAC deal…SRNG and Gingko Bioworks.
https://www.forbes.com/sites/johncumbers/2020/06/25/if-biology-can-build-it-they-will-come-ginkgo-bioworks-is-laying-the-foundation-for-the-4-trillion-bioeconomy/?sh=1ca8193841e0
👍️0
janeyH janeyH 3 years ago
this is in my biosynthetic basket
👍️0
janeyH janeyH 3 years ago
'sup rt?
👍️0
rtrstock rtrstock 4 years ago
I've decided to start focusing on trading Initial Offerings again, it seemed percentage gainwise, to be strategical. So this is my next play.
👍️0

Your Recent History

NASDAQ
ZY
Zymergen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved